Chapter
The Future of Manufacturing and Healthcare
34:24 - 40:17 (05:52)
The future of manufacturing will be increasingly focused on using carbon and other materials for structural purposes. In addition, healthcare and other basic necessities should be made freely available to all people.
Clips
The philanthropy governor allows individuals like Bill Gates to take on multi-year quests such as eradicating malaria or polio, that exceed the budget of GDPs of nations, while corporate health plans may allow for experimentation in universal basic income as food, shelter, clothing, and health care become cheaper.
34:24 - 35:48 (01:24)
Summary
The philanthropy governor allows individuals like Bill Gates to take on multi-year quests such as eradicating malaria or polio, that exceed the budget of GDPs of nations, while corporate health plans may allow for experimentation in universal basic income as food, shelter, clothing, and health care become cheaper. The speaker also questions the idea of holding on to wealth as a billionaire.
ChapterThe Future of Manufacturing and Healthcare
Episode#317: Steve Jurvetson — The Midas Touch and Mind-Bending Futures
PodcastThe Tim Ferriss Show
The future of manufacturing is shifting towards nanotech and carbon-based materials, making it lighter and more efficient.
35:48 - 38:35 (02:46)
Summary
The future of manufacturing is shifting towards nanotech and carbon-based materials, making it lighter and more efficient. There's potential for healthcare to be provided for free and for the information search of health to also become free.
ChapterThe Future of Manufacturing and Healthcare
Episode#317: Steve Jurvetson — The Midas Touch and Mind-Bending Futures
PodcastThe Tim Ferriss Show
Patrick Collison and Tyler Cowen discuss the future of drug manufacturing, including the role of generics, intellectual property, and computational power in reducing costs and increasing access to medication.
38:35 - 40:17 (01:42)
Summary
Patrick Collison and Tyler Cowen discuss the future of drug manufacturing, including the role of generics, intellectual property, and computational power in reducing costs and increasing access to medication. They also explore the transition towards personalized medicine and the potential changes to clinical trials.